This session discusses medication-assisted treatment (MAT) in drug courts and the general criminal justice system and describes the current FDA approved treatments of Opioid Use Disorders. At the end of this session, participants will be able to identify the biological basis for addiction and substance abuse; identify goals for treatment; know the medications currently FDA-approved for the treatment of Opioid Use Disorders; understand the effectiveness of MAT for Opioid Use Disorders; know what NADCP’s Best Practice Standards say about MAT in drug courts; understand the legal standards for MAT in the criminal justice population; recognize how physicians decide on treatment changes and reduce the risk of diversion; and know how to locate qualified medication-assisted treatment providers.
Dr. Marlowe is Sr. Scientific Consultant at NADCP, Sr. Science & Policy Advisor for Alcohol Monitoring Systems, and a faculty member at the Global Inst for Forensic Research. Previously he was Chief of Science, Law & Policy for NADCP, Dir of Law & Ethics Research at the Treatment Research Inst, and Adjunct Associate Professor of Psychiatry at University of Pennsylvania School of Medicine. A lawyer & clinical psychologist, he focuses on the impact of coercion in substance use disorder treatment, effects of drug courts & other rehabilitation programs for persons with substance use disorders involved in the justice system, and behavioral treatment for persons with substance use disorders & criminal involvement. He has published over 175 articles, monographs, books, & book chapters on correctional rehabilitation, forensic psych, & treatment of substance use disorders.